The AIDS Institute is lead by Dr. Irvin Chen, Director, and four Associate Directors with responsibility for specific program areas, in addition to forging collaborations between programs.
Dr. Chen obtained his BA at Cornell and his PhD at the University of Wisconsin, under the guidance of Nobel Laureate Dr. Howard Temin. Dr. Chen continued postdoctoral studies with Dr. Temin and with Dr. David Golde at UCLA. Since 1990, Dr. Chen has been a professor in the Department of Microbiology & Immunology and in the Department of Medicine in the UCLA School of Medicine. He is an internationally renowned investigator in cancer and AIDS research, and he has made significant scientific contributions to the study of the human retroviruses, including HIV. His latest work is focused on utilizing gene therapy to treat and ultimately cure HIV/AIDS.
Dr. Coates joined the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA in 2003. His areas expertise are HIV prevention, the relationships between prevention and treatment and between biological and social/behavioral prevention strategies, and HIV policies. His domestic work has focused on men who have sex with men, and he has recently completed a nationwide clinical trial of an experimental HIV-preventive intervention focused on this population. In addition Dr. Coates is directing a clinical trial in South Africa, Zimbabwe, Tanzania, and Thailand to determine the impact of strategies for destigmatizing HIV on HIV incidence community-wide. He is co-principal investigator of the NIAID-funded HIV Prevention Trials Network (HPTN).
Ronald Mitsuyasu, MD, Associate Director, Clinical Therapeutics and Biomedical Prevention Program
Dr Mitsuyasu is the Director of the Center for Clinical AIDS Research and Education (CARE) at UCLA and a Professor of Medicine in Residence at the UCLA David Geffen School of Medicine. After completing his residency at Rush University in 1981, and a fellowship in Hematology-Oncology at UCLA in 1984 he joined the UCLA faculty in the Division of Hematology-Oncology. He is an expert in both immune-based therapies for HIV and in treatment of AIDS-related malignancies. In addition, he is the current chair of the AIDS Malignancy Consortium, which is a collaborative network funded by the National Cancer Institute to conduct clinical trials for AIDS-related malignancies.
Gail Wyatt, PhD, Associate Director, Prevention and Clinical Research Program
Dr Wyatt is a licensed Clinical Psychologist, a board certified sex therapist and a Professor of Psychiatry and Biomedical Sciences at the Semel Institute for Neuroscience and Behavior at UCLA. Dr. Wyatt directs the Sexual Health Program, the NIH funded Phodiso Training Project in South Africa and the HIV/AIDS Translational Training Program. She has been internationally recognized for her work in Jamaica, Africa, India and most recently South Africa where she conducts a longitudinal study of the aftermath of rape among South African women. She has numerous books and journal articles, makes countless presentations to academic and community and has been recognized for her mentoring and research.
Dr. Zack obtained his PhD in Immunology from University of Texas Southwestern. He joined the UCLA Faculty in 1991 and is currently a Professor in the Departments of Medicine as well as Microbiology, Immunology & Molecular Genetics at the David Geffen School of Medicine. He is the author of more than 150 scientific publications, and is best known for his innovative work HIV replication, in addition to developing new therapeutic approaches for eradicating the AIDS virus. Among his many honors, Dr. Zack is the recipient of the Pediatric AIDS Foundation's "Elizabeth Glaser Scientist Award," and the Ohio State University Center for Retrovirus Research "Distinguished Research Career Award."